Organ transplantation remains one of the most powerful lifesaving tools in modern medicine, yet demand continues to far exceed supply. In January 2026, U.S. health officials introduced a sweeping federal proposal aimed at expanding the use of donor organs, strengthening oversight, and restoring public trust in the transplant system. The initiative, led by the Centers for Medicare and Medicaid Services, focuses on improving accountability among organ procurement organizations while encouraging broader acceptance of medically complex organs.
This new plan comes at a critical moment for transplant medicine in the United States. With more than 100,000 patients currently on the national transplant waiting list and thousands dying each year before receiving an organ, even small improvements in donation efficiency could translate into thousands of lives saved.
The U.S. transplant system has long struggled with a persistent shortage of donor organs, particularly kidneys. While medical advances have improved surgical outcomes and post transplant survival, the number of available organs has not kept pace with rising demand.
According to federal data, most patients on the waiting list are seeking kidney transplants, often spending years on dialysis while hoping for a suitable donor. Dialysis can prolong life, but it significantly reduces quality of life and increases the risk of serious complications.
In 2025, the situation worsened when donations from deceased donors declined for the first time in more than a decade. At the same time, transplant growth slowed. Just over 49,000 transplants were performed nationwide, only a modest increase from the previous year. This slowdown has alarmed policymakers, clinicians, and patient advocates alike.
Organ procurement organizations, commonly known as OPOs, play a central role in the transplant system. These nonprofit entities are responsible for identifying potential donors, recovering organs from deceased individuals, and coordinating with transplant centers to match organs with recipients.
There are dozens of OPOs operating across the United States, each serving a specific geographic region. While some organizations consistently recover and place a high number of usable organs, others lag behind. Performance disparities among OPOs have been a longstanding concern for federal regulators.
Under the current system, underperforming OPOs have often faced limited consequences. The new CMS proposal seeks to change that.
The CMS plan introduces several major reforms designed to increase organ availability and improve patient safety. At its core, the proposal emphasizes accountability, transparency, and better utilization of available donor organs.
One of the primary objectives is to tighten federal oversight of OPOs. The proposed rule would clarify performance expectations and give CMS stronger authority to remove organizations that consistently fail to meet benchmarks.
CMS Administrator Dr. Mehmet Oz emphasized the urgency of this effort, stating that every missed opportunity for organ donation represents a life lost. The new framework aims to ensure that no viable organ goes unused due to inefficiency or poor coordination.
A major focus of the plan is expanding the use of medically complex organs. These organs typically come from older donors or individuals with underlying health conditions such as hypertension or diabetes.
Historically, many transplant centers have been reluctant to accept these organs due to concerns about shorter graft survival. However, research has shown that even organs with lower expected longevity can provide significant benefit, particularly for older or critically ill patients.
For example, a kidney that may not be ideal for a young recipient could still offer several years of dialysis free life to an older patient. For many individuals, this difference can be life changing.
The CMS proposal would require OPOs to better track how medically complex organs are recovered, evaluated, and placed. The goal is to ensure these organs are matched with appropriate recipients rather than discarded.
The proposed rule emphasizes better data reporting and tracking. Medically complex organs often require additional evaluation and coordination, and CMS wants clearer insight into how these organs move through the system.
By improving data transparency, regulators hope to identify bottlenecks, highlight best practices, and reduce unnecessary organ refusals.
While many patient advocates have welcomed the proposal, the response within the transplant community has been mixed.
Jeff Trageser, president of the Association of Organ Procurement Organizations, expressed cautious optimism. He noted that maximizing transplant opportunities requires cooperation across the entire healthcare system. Hospitals must support timely donation, OPOs must manage complex donors effectively, and transplant centers must be prepared to use organs that fall outside traditional criteria.
Some transplant centers remain hesitant to accept medically complex organs due to regulatory pressures and outcome reporting requirements. Poor transplant outcomes, even when expected, can negatively impact a center’s performance metrics. CMS officials have indicated that aligning incentives will be critical to the success of the new plan.
Beyond logistical challenges, public confidence in the transplant system has taken a significant hit in recent years. Reports of patients nearly having organs removed while still showing signs of life sparked widespread outrage and fear.
Although those procedures were halted and investigations launched, the damage to public trust was substantial. Thousands of individuals reportedly removed themselves from organ donor registries following the incidents.
Rebuilding confidence is now a central concern for federal health officials. Transparency, clear safety protocols, and stronger oversight are all intended to reassure the public that organ donation is both ethical and safe.
For patients on the transplant waiting list, the CMS proposal represents hope. Expanded use of medically complex organs could significantly shorten wait times, especially for older adults and those with advanced illness.
Even modest increases in organ utilization could save thousands of lives each year. A kidney transplant, for example, not only extends life but also reduces long term healthcare costs by eliminating the need for ongoing dialysis.
For families of donors, the plan also reinforces the value of their decision. Ensuring that every possible organ is used honors the gift of donation and maximizes its impact.
CMS has indicated that it plans to finalize the proposed rule later in 2026. Before that happens, the proposal will undergo a public comment period, allowing healthcare organizations, patient groups, and individuals to provide feedback.
If implemented effectively, the reforms could mark one of the most significant overhauls of the U.S. transplant system in decades. Success will depend on careful execution, collaboration among stakeholders, and continued monitoring to ensure patient safety remains paramount.
This federal initiative reflects a broader shift in healthcare policy toward maximizing existing resources rather than relying solely on new technologies. While advances such as artificial organs and regenerative medicine remain on the horizon, improving the efficiency of today’s transplant system offers immediate benefits.
By embracing medically complex organs and holding underperforming organizations accountable, the United States may be able to turn a period of decline into a new era of progress for transplant medicine.
For the more than 100,000 Americans waiting for a transplant, these changes cannot come soon enough.
The Associated Press, January 28, 2026
This article is for informational and educational purposes only and does not constitute medical advice. Statistical data and general medical information reflect population level trends and may not apply to individual circumstances. Always consult a qualified healthcare professional for personalized medical advice, diagnosis, or treatment decisions.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.